市场有风险，投资需谨慎。本文不构成个人投资建议，也未考虑到个别用户特殊的投资目标、财务状况或需要。用户应考虑本文中的任何 意见、观点或结论是否符合其特定状况。据此投资，责任自负。 中微公司：预计2025年净利润为20.80亿元至21.80亿元，同比增长约28.74%至34.93%。 风险提示及免责条款 ...

AI基金东方人工智能主题混合A（005844）披露2025年四季报，第四季度基金利润163.23万元，加权平均基金份额本期利润0.0041元。报告期内，基金净值 增长率为1.22%，截至四季度末，基金规模为6亿元。 该基金属于偏股混合型基金，长期投资于TMT股票。截至1月22日，单位净值为2.026元。基金经理是严凯，目前管理的3只基金近一年均为正收益。其中， 截至1月22日，东方惠新灵活配置混合A近一年复权单位净值增长率最高，达105.58%；东方创新科技混合最低，为88.54%。 基金管理人在四季报中表示，在 AI 产业爆发式增长与国内半导体产业国产化加速推进的双重背景下，我们聚焦兼具这两大趋势的投资方向。本基金重点布 局半导体芯片产业链的短板领域，尤其关注半导体设备、材料及零组件等关键环节——这些领域不仅技术壁垒高、市场竞争优势显著，更深度受益于国家政 策扶持，具备充足的发展动力。展望未来，本基金将继续紧密跟踪半导体产业国产化进程，深度挖掘技术创新所蕴含的长期投资价值与回报机遇。 截至1月22日，东方人工智能主题混合A近三个月复权单位净值增长率为37.55%，位于同类可比基金1/229；近半年复权单位净 ...

《科创板日报》1月23日讯，今日科创板早报主要内容有：九部门鼓励药品零售企业依法开展横向并购 与重组；马斯克表示计划明年面向公众销售Optimus机器人；小米集团宣布最高25亿港元的自动股份回 购计划；国产GPU厂商燧原科技科创板IPO获受理。 《科创板日报》主播小K为您播报。 【市场动态】 九部门：鼓励药品零售企业依法开展横向并购与重组 商务部等9部门关于促进药品零售行业高质量发展的意见，支持零售药店进行兼并重组。鼓励药品零售 企业依法开展横向并购与重组。鼓励各地优化营商环境，对于被整合的连锁或单体药店，优化《药品经 营许可证》申请核发流程。涉及医保资质变更的，允许原医保资质继续存续和使用，新医保资质正式开 通后，注销原医保资质。 穿越者公司已获首批20余位太空游客预定 预计2028年实现载人首飞 北京穿越者载人航天科技有限公司举行"太空旅游全球发布会"，国内首艘商业载人飞船"穿越者壹号 （CYZ1）"全尺寸试验舱首次公开展示。"穿越者壹号（CYZ1）"技术团队会前表示，目前已预订了超 三艘船，合计20余位太空游客，预计2028年将实现载人首飞。会上，首批太空游客亮相，包括中国工程 院院士李立浧、智元机器人 ...

Group 1 - The A-share market experienced fluctuations at relatively high levels in Q4 2025, with a slight decrease in overall equity positions of public funds compared to Q3 2025 [1][2] - The average equity positions for stock and mixed funds were 89.06% and 81.05%, respectively, showing a minor decline from the previous quarter [2] - Major holdings in public funds included leading light module companies, with Zhongji Xuchuang and Xinyi Sheng surpassing Ningde Times and Tencent Holdings to become the top two heavyweights [1][4] Group 2 - Several actively managed equity funds significantly increased their positions, with notable examples including Bosera Huixing and GF Chengxiang, which raised their equity positions by 12.31 and 10.3 percentage points, respectively [2] - Fund managers expressed optimism about the A-share market for 2026, citing potential dual benefits from domestic and international liquidity [3][9] - The focus on technology sectors continued, with managers identifying investment opportunities in storage chips, solid-state batteries, and humanoid robots [7][10] Group 3 - The top 50 heavyweights in public funds were primarily concentrated in information technology, consumer goods, and investment sectors, with 18 stocks in the information technology sector [4][6] - AI-related stocks gained prominence, with Zhongji Xuchuang, Xinyi Sheng, and Hanwujing entering the top seven heavyweights due to the AI boom [4][6] - The number of innovative drug companies in the top 50 heavyweights decreased from eight to five by the end of Q4 2025, indicating a shift in investment focus [5] Group 4 - Fund managers anticipate that the AI investment theme will continue to be a primary focus, with expectations for rapid growth in AI applications in the coming years [9][10] - The investment strategy is shifting towards AI applications, including smart driving, edge AI, and humanoid robots, as the industry matures [9][10] - The overall sentiment among fund managers is that the AI-driven technology market will remain a significant area of investment for the next several years [9][10]

不触发要约收购义务 减持数量：626.15万股，占总股本1% 减持方式：大宗交易 减持期间：2026年1月6日至1月21日 减持价格：304.76-346.97元/股 减持金额：20.63亿元 完成情况：已按计划完成 三、减持后持股情况 当前持股：8,722.21万股 持股比例：13.93%（由14.93%降至13.93%） 四、其他说明 本次减持符合此前披露的减持计划，未违反承诺 公司无控股股东和实际控制人，本次减持不改变公司治理结构 减持前持股：9,348.35万股，占总股本14.93% 二、减持实施情况 中微公司：5%以上股东减持完成公告要点 一、减持主体基本情况 股东名称：上海创业投资有限公司（5%以上股东，非控股股东） ...

证券代码：688012 证券简称：中微公司 公告编号：2026-009 中微半导体设备（上海）股份有限公司 关于持股 5%以上股东权益变动触及 1%刻度暨减持 股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有的基本情况 本次减持计划实施前，上海创业投资有限公司（以下简称"上海创投"）持 有中微半导体设备（上海）股份有限公司（以下简称"中微公司"或"公 司"）股份 93,483,533 股，占公司总股本的 14.93%。 减持计划的实施结果情况 公司于 2025 年 12 月 1 日披露了《大股东大宗交易减持股份计划公告》，上 海创投计划自公告披露之日起 15 个交易日后的 3 个月内，在符合法律法规 规定的减持前提下，通过大宗交易方式减持公司股票不超过总股本的 1%， 即 6,261,453 股。 近日，公司收到上海创投出具的《关于股份减持情况的告知函》，上海创投 通过大宗交易已累计减持中微公司股份 6,261,453 股,减持股份数量已达 到中微公司股份总数的 1%，本 ...

格隆汇1月22日丨中微公司(688012.SH)公布，近日，公司收到上海创投出具的《关于股份减持情况的告 知函》，上海创投通过大宗交易已累计减持中微公司股份626.15万股,减持股份数量已达到中微公司股份 总数的1%，本次减持计划已实施完毕。 ...

中微公司公告称，持股5%以上股东上海创投实施减持计划，于2026年1月6日至1月21日，通过大宗交易 减持公司股份6,261,453股，占总股本1%，减持总金额20.63亿元，减持价格区间为304.76 - 346.97元/ 股。减持后，上海创投持股比例由14.93%降至13.93%，本次减持计划已实施完毕，且与此前披露计 划、承诺一致，不触及要约收购，也不影响公司治理结构和持续经营。 ...

今日（1月22日）市场主要指数集体高开，石油石化、国防军工涨超3%。 盘面上，石油开采及服务板块大幅拉升，石化油服、洲际油气、蓝焰控股等涨停，潜能恒信涨超10%。 燃气股走强，胜利股份涨停，凯添然气、胜通能源、蓝天燃气等涨幅居前。 商业航天概念涨幅居前，板块内，中国一重（维权）、中超控股、中信重工等逾10股涨停，三角防务、 天力复合、江航装备等涨超10%。 AI应用概念活跃，浙文互联、国安股份涨停，华凯易佰、深信服等涨超10%。 新股速递：N国亮开盘涨超2倍 N国亮（920076）今日在北交所上市，开盘价33.11元，上涨207.71%。 | | | | U9:45 30.61 | 49 | | --- | --- | --- | --- | --- | | | | | 09:45 30.60 | 72 | | | | | 09:45 30.60 | 88 | | | | | 09:45 30.65 272 | | | | | | 09:45 30.65 | 67 | | | | | 09:45 30.65 | ୧3 | | 09:30 | 11:30 | 15:00 | NO. AS 20 65 | 11 ...

Summary of the Conference Call on Global Semiconductor Capital Equipment Industry Overview - The focus is on the **Wafer Fabrication Equipment (WFE)** market, particularly imports to **China**. - In **2025**, total WFE imports to China reached **$39.2 billion**, representing a **3% year-over-year (YoY)** increase, despite a **13% YoY** decline in December imports due to a high base effect from December 2024 [2][26][37]. Key Insights - **December 2025** saw WFE imports of **$4.5 billion**, marking the highest monthly figure for the year, with a **MoM increase of 84%** [2][3][26]. - **Lithography imports** hit a record high in December at **$2.3 billion**, primarily driven by demand from **Shanghai** and **Beijing** [3][27][35]. - The overall demand for WFE in China remains robust, particularly for **AI chip and memory production**, indicating a continued push for local production capabilities [3][68]. Company-Specific Insights ASML - ASML's China sales are projected to reach **EUR 3.14 billion** in Q4 2025, reflecting a **35% QoQ** and **64% YoY** increase, driven by high lithography imports [4][68][70]. - China is expected to account for **42%** of ASML's total system sales in Q4 2025, significantly higher than previous guidance [68][79]. Lam Research (LRCX) - December revenues for LRCX are expected to decline by **42% QoQ**, with China exposure estimated at **25%** of total revenues [6][90]. - The company anticipates that its China revenue exposure will fall below **30%** in 2026 [6][90]. Applied Materials (AMAT) - AMAT's January quarter revenues are projected to increase by **4% QoQ**, with China exposure remaining around **30%** [7][87]. Other Companies - **Tokyo Electron (TEL)** and **Kokusai** are also expected to see growth, with TEL benefiting from competitive pricing and Kokusai from increased adoption of batch ALD technology [17][20]. - **Screen** and **Advantest** are projected to experience declines in China revenue, with Screen's expected to drop **43% YoY** [11][12]. Import Trends - The **US, Singapore, and Malaysia** combined accounted for **35%** of WFE imports to China in 2025, while Japan's share decreased to **23%** [43][50]. - The share of lithography imports from the Netherlands has increased significantly since 2023, indicating a shift in sourcing strategies among global vendors [43][65]. Investment Implications - **NAURA**, **AMEC**, and **Piotech** are highlighted as outperformers in the domestic WFE market, benefiting from local demand and technological advancements [14][15][16]. - **ASML**, **LRCX**, and **AMAT** are also rated as outperformers, with strong growth prospects driven by ongoing demand in the semiconductor sector [19][20][21]. Conclusion - The WFE market in China is showing signs of resilience and growth, particularly in lithography, despite some expected declines in revenue for certain companies. The ongoing investments in local production capabilities for advanced technologies like AI chips and memory are likely to sustain demand in the coming years.